(autophagolysosome formation) using a Zeiss inverted fluorescence microscope with a 560 Axiovision camera.
Immunoblotting
Whole cell lysates from human astrocytes were prepared in RIPA buffer supplemented with a mixture of protease and phosphatase inhibitors and separated by SDS-PAGE for immunoblotting.
Primary antibodies against Beclin1 (1:500) and LC3B (1:1000), were from Novus Biologicals (Littleton, CO, USA). Primary antibody against β-actin (1:200), was from Santa Cruz Biotechnology. Primary antibodies were followed by incubation with a secondary antibody conjugated to horseradish peroxidase (Millipore, Billerica, MA, USA) used at a 1:1000 dilution.
The immunoblots were exposed to SuperSignal West Femto Substrate (Thermo Scientific, Waltham, MA, USA) and visualized using a ChemiDoc imaging system (Bio-Rad, Hercules, CA, USA).
Cell viability assay
Viability of human astrocytes was assessed using a live/dead cell fluorescence assay which combines fluorescent reagents to yield two-color discrimination of the population of live cells Autophagy-related gene expression were measured using qRT-PCR array assays. Of the 48 genes related to the autophagy pathway, only genes that showed a significant fold-change respective to control cells were selected. Several pro-apoptotic genes, including BAK1 and CASP8 were detected in lysates from cells transfected with siBeclin1. The upregulation was further increased when silencing of Beclin1 was combined with morphine. The indicated cell survival related gene expression levels were measured by gene array across the indicated treatment groups. Data are presented as fold of change relative to control cells.
